ASPIRIN AS A PROPHYLAXIS IN PRE-ECLAMPSIA AND ITS COMPLICATIONS IN MEDINA, SAUDI ARABIA

Background: Low-dose aspirin has been used during pregnancy most commonly to prevent or delay the onset of pre-eclampsia. World Health Organization guideline recommended that low-dose aspirin (75 mg/day) be initiated before 20 weeks of gestation for women at high risk of preeclampsia Objective: to investigate the effectiveness of aspirin prescription in the prophylaxis of pre-eclampsia and its complications among Saudi women in almadinah region Method: we sought to examine the influence of compliance on the beneficial effect of aspirin in prevention of preeclampsia in the Aspirin for Evidence-Based Preeclampsia Prevention trial. A cross sectional study was carried out at Al-Madinah Al-Monawarah, Kingdom of Saudi Arabia, including medina city urban and rural area. The study was done at general population at madinah, kingdom of Saudi Arabia. Using an electronic questionnaire that was distributed to population online through different types of social media (e mail, whatsapp and twitter). The sample size is 700. Data was collected by a semi structured questionnaire prepared by the researchers Result: We found that it was effective in 32.1% in the reduction of severity or complication while 49.3% not effective. Conclusion: We found that the use of low-dose aspirin wasn't effective as a prophylaxis of pre-eclampsia and its complications. We recommend doing this study all over the kingdom for more cases and more accurate results.